Medical Packaging results, Q2 2023
Net profit, assets, equity and cash flow for Q2 2023, against the same period a year earlier, from the published financial statements.
Net profit21.1 millionEGP · +267.8% vs the same period a year earlier
Total assets190 millionEGP · +56.6% vs the same period a year earlier
Shareholders' equity162 millionEGP · +105.5% vs the same period a year earlier
Operating cash flow6.86 millionEGP · −72.1% vs the same period a year earlier
In short
- Medical Packaging's net profit for Q2 2023 was about 21.1 million EGP, up +267.8% from 5.74 million EGP in Q2 2022.
- Total assets at the end of Q2 2023 were about 190 million EGP, and shareholders' equity about 162 million EGP.
- Operating cash flow for Q2 2023 was positive at 6.86 million EGP.
Key lines against the same period a year earlier
This periodQ2 2022Change
Net profit21.1 million5.74 million+267.8%
Gross profit48.66 million24.26 million+100.6%
Total assets190 million121 million+56.6%
Total liabilities28 million42.5 million−34.1%
Shareholders' equity162 million78.76 million+105.5%
Total liabilities and equity190 million121 million+56.6%
Operating cash flow6.86 million24.64 million−72.1%
Investing cash flow-252 thousand-854 thousand+70.5%
Financing cash flow29.52 million-12.82 million+330.2%
Net change in cash36.14 million10.96 million+229.7%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Medical Packaging's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy